Community acquired Pseudomonas pneumonia in an immune competent host

Mehrnaz Asadi Gharabaghi1, Seyed Mojtaba Mir Abdollahi, Enayat Safavi

  • 1Department of Pulmonary Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran. asadi_m@tums.ac.ir

BMJ Case Reports
|June 7, 2012
PubMed

Insights

Community-acquired Pseudomonas pneumonia is rare in healthy individuals. This case highlights Pseudomonas aeruginosa pneumonia in a previously healthy 26-year-old man with a prolonged cough and malaise.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Background:

  • Pseudomonas aeruginosa is a Gram-negative bacterium.
  • It typically causes hospital-acquired pneumonia or pneumonia in immunocompromised individuals.
  • Risk factors include structural lung disease (e.g., cystic fibrosis) or weakened immune systems.

Observation:

  • A 26-year-old previously healthy male presented with an 8-week history of malaise and cough.
  • The patient had no known risk factors for Pseudomonas aeruginosa infection.
  • This presentation suggested an unusual cause of community-acquired pneumonia.

Findings:

  • The patient was diagnosed with community-acquired pneumonia caused by Pseudomonas aeruginosa.
  • This is an uncommon pathogen for pneumonia in immunocompetent hosts without underlying lung conditions.
  • The prolonged symptoms indicated a persistent infection.

Implications:

  • This case underscores the importance of considering Pseudomonas aeruginosa in the differential diagnosis of community-acquired pneumonia, even in healthy individuals.
  • Further investigation into the specific host-pathogen interactions may be warranted.
  • Highlights the need for timely diagnosis and appropriate antibiotic treatment for atypical pneumonia presentations.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...